Browse by:

Stratus taps Colo. firm to boost resell

John Agoglia |

Maynard-based software provider Stratus Technologies, Inc., is partnering with Arrow Electronics of Englewood, Colo., to expand its reach through Arrow's network of authorized resellers.

Secretary of State alleges billion-dollar Ponzi scheme by Marlborough company

Emily Micucci |

Secretary of State William Galvin has filed a civil complaint against Marlborough marketing firm TelexFREE, alleging the company is "merely a veiled pyramid and Ponzi scheme"...

Weather cuts into CSX earnings for Q1

Emily Micucci |

Weather-related disruptions put a dent in earnings for CSX Corp. in the first quarter, bringing net income down to $398 million, compared to $462 million in 2013, the freight carrier announced.

BSX wins FDA approval on heart devices

Natick-based Boston Scientific Corp. (BSX) has received approval for its newest defibrillators and heart failure devices, including the trademarked Dynagen Mini, Inogen Mini ICDs, and the Dynagen XF...

Natick company receives $3M order

Emily Micucci |

Natick-based Cognex Corp., which manufacturers machine sensors, said it received more than $3 million in purchase orders for its DataMan barcode readers.

Sepaton awarded data deduplication patent

Michael Novinson |

Marlborough-based Sepaton has been awarded a patent for a process that improves deduplication ratios and speed, the company announced Tuesday.

Bose sues over alleged patent infringement

Michael Novinson |

Bose Corp. filed a lawsuit last week against Monster Inc., accusing the California-based rival of infringing on the Framingham-based audio technology company's design for in-ear headphones.

Stratus parent credit rating improves

Michael Novinson |

The credit rating for the parent company of Stratus Technologies has improved after the Maynard-based company announced it was being sold to a private equity firm.

Marlborough firm files for Chapter 11

Michael Novinson |

A Marlborough telecommunications company has filed for Chapter 11 bankruptcy protection to further revise its compensation plan for company associates.

Karyopharm finds clinical partner, possible new uses for cancer drug

Emily Micucci |

Karyopharm Therapeutics of Natick has produced promising results as it develops its cancer drug, KPT-330. Now, the startup is exploring other potential applications for its technology.

Copyright 2014 New England Business Media